Related Experiment Video
Updated: Nov 27, 2025

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Moonlighting in drug metabolism.
1John Curtin School of Medical Research, ANU College of Health and Medicine, The Australian National University, Canberra, ACT, Australia.
Drug metabolizing enzymes (DMEs) perform essential detoxication reactions. This review explores their additional
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology and Toxicology
- Enzymology
Background:
- Drug metabolizing enzymes (DMEs) are crucial for xenobiotic biotransformation.
- These enzymes catalyze diverse reactions like oxidation, conjugation, and hydrolysis.
- DMEs exhibit substrate promiscuity, essential for detoxifying various compounds.
Purpose of the Study:
- To review the multifaceted roles of drug metabolizing enzymes beyond catalysis.
- To highlight the concept of 'moonlighting proteins' within the context of DMEs.
- To explore the physiological significance of these non-catalytic functions.
Main Methods:
- Literature review of existing research on drug metabolizing enzymes.
- Analysis of studies identifying non-catalytic functions of DMEs.
- Synthesis of findings related to moonlighting proteins and their physiological roles.
Main Results:
- Many DMEs function as 'moonlighting proteins' with multiple biochemical roles.
- These moonlighting functions are implicated in vital physiological processes.
- Examples include roles in reproduction, vision, cell signaling, cancer, and transport.
Conclusions:
- Drug metabolizing enzymes possess diverse functions beyond their catalytic roles.
- Understanding these moonlighting functions is critical for comprehending physiology.
- Further research is expected to uncover additional non-catalytic roles of DMEs.
More Related Videos
11:06Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
Related Concept Videos
Drug Biotransformation: Overview
Drug Biotransformation: Overview
Drug Metabolism: Phase I Reactions
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Drug Metabolism: Phase II Reactions